We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$9.03B
AUM Growth
-$1.37B
(-13%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-27.43%
Top 10 Holdings %
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SKX
Skechers
SKX
|
+$18.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$17.4M |
| 3 |
Insmed
INSM
|
+$16.1M |
| 4 |
Gilead Sciences
GILD
|
+$15.8M |
| 5 |
K
Kellanova
K
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$394M |
| 2 |
Amazon
AMZN
|
+$314M |
| 3 |
NVIDIA
NVDA
|
+$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$121M |
| 5 |
Advanced Micro Devices
AMD
|
+$61.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.09% |
| 2 | Consumer Discretionary | 2.5% |
| 3 | Technology | 1.62% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Arbutus Biopharma
ABUS
$857M
| $129K | ﹤0.01% |
41,866
+17,669
| +73% | +$58.7K |
|
|
CCRN
1302
CALL
DELISTED
Cross Country Healthcare
CCRN
| $129K | ﹤0.01% |
+9,900
| New | +$136K |
|
1303
Talkspace
TALK
$874M
| $122K | ﹤0.01% |
43,711
-1,600
| -4% | -$4.71K |
|
1304
CALL
Chegg
CHGG
$110M
| $121K | ﹤0.01% |
+100,000
| New | +$92.5K |
|
1305
Rekor Systems
REKR
$85.8M
| $120K | ﹤0.01% |
+103,404
| New | +$109K |
|
1306
Kopin
KOPN
$652M
| $120K | ﹤0.01% |
78,217
-131,869
| -63% | -$172K |
|
|
BULL
1307
PUT
Webull Corp
BULL
$3.75B
| $120K | ﹤0.01% |
+10,000
| New | +$155K |
|
1308
Intellia Therapeutics
NTLA
$1.49B
| $119K | ﹤0.01% |
12,676
| – | – |
|
1309
New Fortress Energy
NFE
$92.1M
| $113K | ﹤0.01% |
33,900
+14,729
| +77% | +$64K |
|
|
TEAD
1310
PUT
Teads Holding Co
TEAD
$68.7M
| $111K | ﹤0.01% |
+44,900
| New | +$136K |
|
1311
NewAmsterdam Pharma
NAMS
$3.25B
| $109K | ﹤0.01% |
6,000
-24,934
| -81% | -$455K |
|
1312
CALL
Iridium Communications
IRDM
$5.02B
| $109K | ﹤0.01% |
3,600
| – | – |
|
1313
B2Gold
BTG
$5B
| $107K | ﹤0.01% |
29,581
-106,000
| -78% | -$348K |
|
1314
State Street
STT
$50.6B
| $106K | ﹤0.01% |
+1,000
| New | +$92.5K |
|
1315
Scholar Rock
SRRK
$5.67B
| $106K | ﹤0.01% |
3,000
-4,591
| -60% | -$144K |
|
1316
Johnson Controls International
JCI
$88.8B
| $106K | ﹤0.01% |
+1,000
| New | +$92K |
|
|
AUROW
1317
Aurora Innovation Warrant
AUROW
$352M
| $104K | ﹤0.01% |
119,647
+119,441
| +57,981% | +$147K |
|
1318
Patterson-UTI
PTEN
$3.98B
| $104K | ﹤0.01% |
17,500
-120,200
| -87% | -$724K |
|
1319
CALL
Lucid Motors
LCID
$2.88B
| $97.5K | ﹤0.01% |
+4,620
| New | +$111K |
|
1320
Cannae Holdings
CNNE
$639M
| $93.8K | ﹤0.01% |
+4,500
| New | +$83.1K |
|
1321
PUT
Gossamer Bio
GOSS
$82.9M
| $89.5K | ﹤0.01% |
+72,800
| New | +$79.4K |
|
1322
Corvus Pharmaceuticals
CRVS
$1.12B
| $87.3K | ﹤0.01% |
+21,827
| New | +$79.4K |
|
1323
ADT
ADT
$5.58B
| $84.7K | ﹤0.01% |
+10,000
| New | +$81.9K |
|
|
1324
CALL
New Fortress Energy
NFE
$92.1M
| $83K | ﹤0.01% |
25,000
-1,429,100
| -98% | -$6.21M |
|
1325
CALL
Innoviz Technologies
INVZ
$95M
| $82K | ﹤0.01% |
+50,000
| New | +$43.7K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2025 Portfolio in Review
As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Caption Management opened a new position in Skechers worth $20.1M.
- Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
- Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
- Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
- Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
- Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
- Caption Management opened 576 new positions and closed 636 in Q2 2025.
- Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.
Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.